Delivery Order SPE2DB22D1017-SPE2DB25FYSCF
- Not listed
- The Defense Logistics Agency awarded a $3,086.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with an ultimate completion date of September 2, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Onfil 10 mg tablets (100-count units) valued at $11,683.85 under a firm fixed-price contract type. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Onfil 10 mg tablets (100-count units) with a ceiling value of $4,414.14. This competitive, non-set-aside award reflects a firm fixed-price delivery order placed against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $11,112.74 to AmerisourceBergen Drug Corp for the supply of Onfil 20 mg tablets in quantities of 100 units. This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-competitive set-aside. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $7,366.88 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with an ultimate completion date of May 2, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The...
- The Defense Logistics Agency awarded a $4,906.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for 100 tablets of Onfil 10 mg. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,638.32 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with performance in Conshohocken, Pennsylvania. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 26, 2025. The delivery order was awarded on August 25, 2025, and represents a single pharmaceutical transaction under AmerisourceBergen's broader federal contracting relationship. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,593.44 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with performance in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price contract was executed on August 19, 2025, with an ultimate completion date of August 20, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $3,589.68 to AmerisourceBergen Drug Corp for Onfil 10 mg tablets (100 count) on July 10, 2025, with completion expected by July 11, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX, valued at $999,999,999.00 through December 2026). The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Onfil 20 mg with a ceiling value of $11,018.34. This firm fixed-price, competitively awarded delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The award represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA, leveraging the company's established capabilities as a major pharmaceutical...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSCFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,150.72 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Onfil 20 mg tablets (100-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by September 29, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare systems. The company's extensive portfolio of competitively awarded federal contracts demonstrates its capability to fulfill diverse medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Through its DLA prime vendor arrangement, AmerisourceBergen provides both brand-name and generic pharmaceutical products to support the Defense Logistics Agency's medical supply chain operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.2k | 9/26/25 |